Citations are updated once a week. Recently added citations may not appear.
The suggestion is based on each study and bacteria having different weight based on a multitude of factors. For example, how severe a shift is seen.
| Context | Citation |
|---|---|
| Increases Roseburia - : enterococcus faecium {E. faecium} |
📓
Enterococcus faecium GEFA01 alleviates hypercholesterolemia by promoting reverse cholesterol transportation via modulating the gut microbiota-SCFA axis. Frontiers in nutrition (Front Nutr ) Vol: 9 Issue Pages: 1020734 Pub: 2022 Epub: 2022 Nov 8 Authors Xu W , Zou K , Zhan Y , Cai Y , Zhang Z , Tao X , Qiu L , Wei H , Html Article Publication |
| Increases Roseburia - : enterococcus faecium {E. faecium} |
📓
Effects of dietary supplementation of probiotic Enterococcus faecium on growth performance and gut microbiota in weaned piglets. AMB Express (AMB Express ) Vol: 9 Issue 1 Pages: 33 Pub: 2019 Mar 1 Epub: 2019 Mar 1 Authors Hu C , Xing W , Liu X , Zhang X , Li K , Liu J , Deng B , Deng J , Li Y , Tan C , Html Article Publication |
| Decreases Roseburia - : enterococcus faecium {E. faecium} |
📓
Effect of probiotics on gut microbiome in patients with administration of surgical antibiotic prophylaxis: A randomized controlled study. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy (J Infect Chemother ) Vol: 26 Issue 8 Pages: 795-801 Pub: 2020 Aug Epub: 2020 Apr 10 Authors Kaku N , Matsumoto N , Sasaki D , Tsuda K , Kosai K , Uno N , Morinaga Y , Tagami A , Adachi S , Hasegawa H , Osaki M , Yanagihara K , Publication |
| 0 😁 | 😢 0 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]
